EURK vs GPAT

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for EURK just turned positive on September 21, 2026. Looking at past instances where EURK's MACD turned positive, the stock continued to rise in 4 of 28 cases over the following month. The odds of a continued upward trend are 14%.

The Aroon Indicator entered an Uptrend today. In 2 of 191 cases where EURK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 1%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EURK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 6%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (57.514) is normal, around the industry mean (-542.660). P/E Ratio (-19.653) is within average values for comparable stocks, (117.432). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (15.932). Dividend Yield (0.000) settles around the average of (0.020) among similar stocks. EURK's P/S Ratio (0.000) is very low in comparison to the industry average of (3.158).

The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. EURK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EURK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on GPAT as a result. In 4 of 49 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 8%.

The Moving Average Convergence Divergence (MACD) for GPAT just turned positive on October 15, 2026. Looking at past instances where GPAT's MACD turned positive, the stock continued to rise in 2 of 36 cases over the following month. The odds of a continued upward trend are 6%.

GPAT moved above its 50-day moving average on October 13, 2026 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. GPAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.179) is normal, around the industry mean (-542.660). P/E Ratio (44.180) is within average values for comparable stocks, (117.432). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (15.932). Dividend Yield (0.000) settles around the average of (0.020) among similar stocks. GPAT's P/S Ratio (0.000) is very low in comparison to the industry average of (3.158).

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GPAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.